Thompson_2004_Expert.Opin.Drug.Saf_3_425

Reference

Title : The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease - Thompson_2004_Expert.Opin.Drug.Saf_3_425
Author(s) : Thompson S , Lanctot KL , Herrmann N
Ref : Expert Opin Drug Safety , 3 :425 , 2004
Abstract : Thompson_2004_Expert.Opin.Drug.Saf_3_425
ESTHER : Thompson_2004_Expert.Opin.Drug.Saf_3_425
PubMedSearch : Thompson_2004_Expert.Opin.Drug.Saf_3_425
PubMedID: 15335298

Related information

Citations formats

Thompson S, Lanctot KL, Herrmann N (2004)
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease
Expert Opin Drug Safety 3 :425

Thompson S, Lanctot KL, Herrmann N (2004)
Expert Opin Drug Safety 3 :425